1-5 of 5
Asha B. Pillai
Close
Sort by
Journal Articles

A Single Institution Experience of Bortezomib for Gvhd in a Pediatric HSCT Population

Devangi Shah, Jennifer Reichbach Douglas, DNP, APRN, CPHON, Jumana Ashy, Gregory Suhrheinrich, Edward Dela Ziga, MD, Asha B. Pillai, MD, Julio C Barredo, MD, Warren Alperstein, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5680.
https://doi.org/10.1182/blood-2019-125884
Published: 2019
Journal Articles

Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine β-thalassemia

Shuyu E, Aman Seth, Peter Vogel, Matt Sommers, Taren Ong, Asha B. Pillai
Journal: Blood
Blood (2017) 129 (22): 3017–3030.
https://doi.org/10.1182/blood-2016-03-704387
Published: 2017
Includes: Supplemental data
Journal Articles

Host natural killer T cells induce an interleukin-4–dependent expansion of donor CD4 + CD25 + Foxp3 + T regulatory cells that protects against graft-versus-host disease

Asha B. Pillai, Tracy I. George, Suparna Dutt, Samuel Strober
Journal: Blood
Blood (2009) 113 (18): 4458–4467.
https://doi.org/10.1182/blood-2008-06-165506
Published: 2009
Includes: Supplemental data
Journal Articles

Interaction between Host Natural Killer T Cells and Donor CD4 + CD25 + T reg Cells Protects Against GVHD after TLI/ATS Host Conditioning and Bone Marrow Transplantation.

Asha B. Pillai, MD, Suparna Dutt, Ph.D., Tracy I. George, M.D., Samuel A. Strober, M.D.
Journal: Blood
Blood (2006) 108 (11): 445.
https://doi.org/10.1182/blood.V108.11.445.445
Published: 2006
Journal Articles

Donor CD8+ T Cells Facilitate Graft-Versus-Tumor Effect Via Alloantigen Rather Than Tumor-Specific Antigen Recognition Following Murine Myeloablative BMT.

Asha B. Pillai, MD, Pearline A. Teo, BS, Aditi Mukhopadhyay, BS, Samuel Strober, MD
Journal: Blood
Blood (2004) 104 (11): 3051.
https://doi.org/10.1182/blood.V104.11.3051.3051
Published: 2004